UY29387A1 - Imidazoles sustituidos con heterociclilamida. - Google Patents

Imidazoles sustituidos con heterociclilamida.

Info

Publication number
UY29387A1
UY29387A1 UY29387A UY29387A UY29387A1 UY 29387 A1 UY29387 A1 UY 29387A1 UY 29387 A UY29387 A UY 29387A UY 29387 A UY29387 A UY 29387A UY 29387 A1 UY29387 A1 UY 29387A1
Authority
UY
Uruguay
Prior art keywords
heterociclilamide
imidazols
replaced
prophylaxis
diseases
Prior art date
Application number
UY29387A
Other languages
English (en)
Inventor
Dr Holger Zimmermann
Dr David Bruckner
Dr Kerstin Henninger
Dr Ulrich Rosentreter
Dr Martin Hendrix
Dr Jorg Keldenich
Dr Dieter Lang
Dr Martin Radtke
Dr Daniela Paulsen
Dr Armin Kern
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36675125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29387(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of UY29387A1 publication Critical patent/UY29387A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención se refiere a imidazoles sustituidos cn heterociclilamida y procedimientos para su preparación, su uso para el tratamiento y/o profilaxix de enfermedades asi como su uso para la preparación de medicamentos para el tratamiento y/o profilaxix de enfermedades, especielmente para el uso como agente antivirales, especialmente contra citomegalovirus.
UY29387A 2005-02-23 2006-02-20 Imidazoles sustituidos con heterociclilamida. UY29387A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005008183A DE102005008183A1 (de) 2005-02-23 2005-02-23 Heterocyclylamid-substituierte Imidazole

Publications (1)

Publication Number Publication Date
UY29387A1 true UY29387A1 (es) 2006-10-02

Family

ID=36675125

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29387A UY29387A1 (es) 2005-02-23 2006-02-20 Imidazoles sustituidos con heterociclilamida.

Country Status (29)

Country Link
US (1) US7919489B2 (es)
EP (1) EP1853582B1 (es)
JP (1) JP5208522B2 (es)
KR (1) KR101276003B1 (es)
CN (1) CN101128455B (es)
AR (1) AR053141A1 (es)
AT (1) ATE446292T1 (es)
AU (1) AU2006218276C1 (es)
BR (1) BRPI0607995B8 (es)
CA (1) CA2598521C (es)
DE (2) DE102005008183A1 (es)
DK (1) DK1853582T3 (es)
ES (1) ES2333249T3 (es)
GT (1) GT200600077A (es)
HK (1) HK1110857A1 (es)
HN (2) HN2006007774A (es)
IL (1) IL185050A (es)
MX (1) MX2007010308A (es)
MY (1) MY140543A (es)
NO (1) NO338997B1 (es)
NZ (1) NZ560811A (es)
PE (2) PE20100233A1 (es)
PL (1) PL1853582T3 (es)
PT (1) PT1853582E (es)
RU (1) RU2415851C2 (es)
TW (1) TWI388553B (es)
UY (1) UY29387A1 (es)
WO (1) WO2006089664A2 (es)
ZA (1) ZA200707412B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
CN104610160A (zh) * 2013-11-04 2015-05-13 南京大学 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用
CN104016925B (zh) * 2014-06-17 2016-03-30 遵义医学院 4-烷基咪唑-2-羧酸的合成方法
EP3312170A4 (en) 2015-06-22 2018-12-12 Sumitomo Dainippon Pharma Co., Ltd. 1,4-di-substituted imidazole derivative
JP6507976B2 (ja) * 2015-09-30 2019-05-08 東レ株式会社 イミダゾール−２−カルボン酸エステル誘導体又はその塩の製造方法
CN116120238B (zh) * 2023-03-01 2023-09-22 山东梅奥华卫科技有限公司 一种咪唑衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342501B1 (en) 1994-02-25 2002-01-29 The Regents Of The University Of Michigan Pyrrolo[2,3-d] pyrimidines as antiviral agents
DE69826695T2 (de) * 1997-05-23 2006-02-02 Bayer Pharmaceuticals Corp., West Haven Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
WO1999023091A1 (en) 1997-11-03 1999-05-14 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
KR20010086091A (ko) 1998-12-09 2001-09-07 이곤 이 버그 치환된 페닐렌디아민 그룹을 함유하는 허프스 바이러스의헤테로사이클릭 카복사미드-함유 티오우레아 억제제
DE10257358A1 (de) 2002-12-09 2004-07-08 Bayer Healthcare Ag Substituierte Pyrrole
DE102004015007A1 (de) 2004-03-26 2005-10-13 Bayer Healthcare Ag Substituierte Imidazole
MXPA06013118A (es) * 2004-05-12 2007-02-28 Schering Corp Antagonistas de cxcr1 y cxcr2 de quimocina.
DE102005008183A1 (de) 2005-02-23 2006-08-31 Bayer Healthcare Ag Heterocyclylamid-substituierte Imidazole

Also Published As

Publication number Publication date
KR20080002772A (ko) 2008-01-04
JP5208522B2 (ja) 2013-06-12
NZ560811A (en) 2010-07-30
HN2006007774A (es) 2010-03-29
NO20074780L (no) 2007-11-01
NO338997B1 (no) 2016-11-07
WO2006089664A2 (de) 2006-08-31
DE502006005182D1 (de) 2009-12-03
EP1853582A2 (de) 2007-11-14
CN101128455A (zh) 2008-02-20
KR101276003B1 (ko) 2013-06-20
US20080176859A1 (en) 2008-07-24
HN2010000128A (es) 2010-03-29
HK1110857A1 (en) 2008-07-25
AR053141A1 (es) 2007-04-25
CA2598521A1 (en) 2006-08-31
DK1853582T3 (da) 2010-01-18
PL1853582T3 (pl) 2010-03-31
WO2006089664A3 (de) 2006-11-02
PT1853582E (pt) 2009-11-13
TWI388553B (zh) 2013-03-11
BRPI0607995B1 (pt) 2019-07-16
PE20100233A1 (es) 2010-04-22
IL185050A (en) 2013-01-31
MX2007010308A (es) 2007-10-17
GT200600077A (es) 2006-10-03
PE20061141A1 (es) 2006-12-29
DE102005008183A1 (de) 2006-08-31
ATE446292T1 (de) 2009-11-15
EP1853582B1 (de) 2009-10-21
CN101128455B (zh) 2013-01-16
IL185050A0 (en) 2007-12-03
AU2006218276C1 (en) 2012-06-28
RU2415851C2 (ru) 2011-04-10
AU2006218276A1 (en) 2006-08-31
MY140543A (en) 2009-12-31
US7919489B2 (en) 2011-04-05
CA2598521C (en) 2012-11-27
TW200700411A (en) 2007-01-01
BRPI0607995A2 (pt) 2009-10-27
AU2006218276B2 (en) 2011-04-07
JP2008531508A (ja) 2008-08-14
RU2007135277A (ru) 2009-03-27
BRPI0607995B8 (pt) 2021-05-25
ES2333249T3 (es) 2010-02-18
ZA200707412B (en) 2008-12-31

Similar Documents

Publication Publication Date Title
ECSP056138A (es) Dihidroquinazolinas sustituidas
UY29387A1 (es) Imidazoles sustituidos con heterociclilamida.
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
UY31133A1 (es) "oxazolidinonas sustituidas y su uso"
UY30178A1 (es) Aril sulfonamidas sustituidas
AR051664A1 (es) Agente contra la demodicosis
UY29189A1 (es) Nonadepsipeptidos acilados ii
UY28313A1 (es) Nonadepsipeptidos acilados
UY29417A1 (es) Agentes endoparasiticidas
UY31717A1 (es) (pirazolilcarbonil) imidazolidinonas sustituidas y su uso
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
IT1396915B1 (it) Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
UY30135A1 (es) Quinolonas sustituidas iii
ATE531698T1 (de) 4-aminocarbonylamino-substitutierte imidazolverbindungen mit antiviraler wirkung
DOP2004000895A (es) Dihidroquinazolinas sustituidas con propiedades antivirales
CU23488B7 (es) Dihidroquinazolinas sustituidas con propiedades antivirales
CU20070201A7 (es) Imidazoles sustituidos con heterociclilamida
ES2422680T3 (es) Composición fungicida agrícola u hortícola y su uso para el control de fitopatógenos

Legal Events

Date Code Title Description
105 Application deemed to be withdrawn (no grant fee paid)

Effective date: 20201204